Overview: business performance in Q3 2024
|
Q3 2024 (in € billion) | Change (in %, compared to Q3 2023) | Organic change (in %, compared to Q3 2023) |
|---|---|---|---|
Group net sales | 5.3 | 1.8 | 3.8 |
EBITDA pre | 1.6 | 11.9 | 16.9 |
Life Science sales | 2.2 | 0.9 | 2.1 |
Healthcare sales | 2.1 | 3.2 | 6.2 |
Electronics sales | 0.9 | 0.8 | 2.4 |